- Home
- AACG vs BNR Comparison
AACG vs BNR Comparison
Compare AACG & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AACG
- BNR
- Stock Information
- Founded
- AACG 1999
- BNR 2014
- Country
- AACG China
- BNR China
- Employees
- AACG N/A
- BNR N/A
- Industry
- AACG Other Consumer Services
- BNR Medical Specialities
- Sector
- AACG Real Estate
- BNR Health Care
- Exchange
- AACG Nasdaq
- BNR Nasdaq
- Market Cap
- AACG 31.9M
- BNR 28.6M
- IPO Year
- AACG N/A
- BNR 2020
- Fundamental
- Price
- AACG $1.01
- BNR $5.38
- Analyst Decision
- AACG
- BNR
- Analyst Count
- AACG 0
- BNR 0
- Target Price
- AACG N/A
- BNR N/A
- AVG Volume (30 Days)
- AACG 55.3K
- BNR 20.0K
- Earning Date
- AACG 11-07-2024
- BNR 11-29-2024
- Dividend Yield
- AACG N/A
- BNR N/A
- EPS Growth
- AACG N/A
- BNR N/A
- EPS
- AACG N/A
- BNR N/A
- Revenue
- AACG $35,747,843.00
- BNR $70,154,674.00
- Revenue This Year
- AACG N/A
- BNR $52.90
- Revenue Next Year
- AACG N/A
- BNR $48.35
- P/E Ratio
- AACG N/A
- BNR N/A
- Revenue Growth
- AACG 15.80
- BNR N/A
- 52 Week Low
- AACG $0.50
- BNR $2.62
- 52 Week High
- AACG $1.65
- BNR $9.99
- Technical
- Relative Strength Index (RSI)
- AACG 57.15
- BNR 80.41
- Support Level
- AACG $0.97
- BNR $4.55
- Resistance Level
- AACG $1.03
- BNR $3.89
- Average True Range (ATR)
- AACG 0.05
- BNR 0.42
- MACD
- AACG -0.01
- BNR 0.23
- Stochastic Oscillator
- AACG 64.29
- BNR 99.26
About AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments are Overseas art study services, Other educational services and K-12 education assessment and other services. Majority of its revenue comes from Overseas art study services.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.